Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and...

Related Keywords

United Kingdom ,United States ,Ben Shamsian Lytham ,Company Or Delcath ,Drug Administration ,Nasdaq ,Company Compensation Committee ,Prnewswire Delcath Systems Inc ,Delcath Systems Inc ,Compensation Committee ,Nasdaq Listing Rule ,Delcath Systems ,Hepatic Delivery System ,Delivery System ,Important Safety Information ,Boxed Warning ,Relations Contact ,